A recent lab-stage study finds that preexposure to the proteins used to treat conditions like hemophilia A could help train the immune system to tolerate rather than attack therapies.
Articles on Vaccines
Displaying 301 - 320 of 930 articles
With the World Trade Organization’s 12th Ministerial Conference – arguably its most important ever – happening next week, attempts to keep it ‘on life support’ may be counterproductive.
Thousands took to streets across Australia to protest COVID19 lockdown measures and vaccine mandates. How are white supremacist and right wing groups capitalising on vaccine hesitancy?
Holding contrarian views - despite a lack of personal expertise - is just part of being human. Here’s the psychology behind what we choose to believe.
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
Moderna claims its scientists alone invented the mRNA sequence used to produce its COVID-19 vaccine. The US government, which helped fund the drug, disagrees.
Properly engaged and monitored, Nigeria’s private sector can do more in COVID vaccination exercise.
With limited vaccines available in early 2021, the CDC had to decide which people received vaccines first. With the help of a supercomputer, researchers have shown that the CDC did an excellent job.
Afrigen will be a technology transfer and training hub: it shares technology and develops skills specifically around how to produce a safe, effective and affordable mRNA vaccine.
To help increase trust in vaccines, researchers analyzed data on adverse events to address safety concerns, and then used cognitive science to show how cognitive biases feed vaccine hesitancy.
The development of COVID vaccines has already been explosive. There are more innovations on the way.
Machine learning algorithms can help public health officials identify areas of high vaccine hesitancy by ZIP code to better target messaging and outreach and counter misinformation.
CC BY-NC-ND23.3 MB (download)
South Africa has a vaccine supply, but the challenge is using the doses effectively before they expire.
By scrapping the requirement, the Indonesian government can improve equality of access to basic services and protections that are sorely needed now and in the post-pandemic future.
Addressing these gaps in the vaccination programme will ensure more people are being protected against the type of cancer.
First CDC signed off on a COVID-19 vaccine for adults, then teens. Now US children ages 5 to 11 are officially eligible for shots. Here’s the science on why each group needs to be considered separately.
When making the decision whether to vaccinate children aged five to 11 against COVID-19, regulators in Canada must rely on sound ethics as well as sound science.
Virologists are beginning to assess which other viruses could have pandemic potential
Regulators are currently reviewing the safety and efficacy data of the Pfizer vaccine for five to 11 year olds before deciding whether to approve its use in this age group.
Public health experts know that schools are likely sites for the spread of disease, and laws tying school attendance to vaccination go back to the 1800s.
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Professor of Microbiology, School of Medicine, University of Washington
-
Professor, School of Social Sciences, The University of Western Australia
-
Professor, School of Public Health, University of Sydney
-
Lecturer in Virology, Queen's University Belfast
-
Associate Professor of Biology, Rochester Institute of Technology
-
Distinguished Professor, Professor of Immunology, RMIT University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney